首页>投融资
Indivior
上市
Indivior PLC于2014年9月26日在英格兰和威尔士的法律下注册成立为一家公共有限公司。他们的业务是由利洁时集团公司,一家在英格兰和威尔士法律下注册成立的公共有限责任公司的一个独立部门进行历史的发展及管理的。他们是一家全球专业制药企业且目前是阿片类药物依赖治疗的全球领导者,在这一领域拥有20多年的经验。
基本信息
-
公司全称Indivior PLC
-
类型疾病治疗药物研发商
-
产业领域医药研发/制造
-
公司人数500人以上
-
地址103-105 Bath Road Slough Berkshire SL1 3UH United Kingdom
-
联系电话1-804-3791090
-
邮箱mark.crossley@indivior.com
-
成立时间2014-01-01
投融资
-
2023-06-12上市未透露未透露
-
2014-12-26IPO未透露未透露
-
2014-12-26上市未透露未透露
-
2014-12-24IPO未透露未透露
- 加载更多
相关投融资企业
收并购
硕腾公司于2012年7月在美国特拉华州成立,是全球领先的最大的动物保健药和疫苗公司之一。作为开发、制造商业化的动物保健药品和疫苗的全球领导者,公司一直致力于提供解决方案来提高动物的健康。
战略投资
Medic Life Sciences Inc是一家美国的生物技术公司,专注于开发创新的医疗设备和诊断技术。公司致力于改善患者的诊断和治疗体验,通过提供高效、便捷的医疗产品和服务,满足医疗市场的需求。其主要产品线包括医疗影像设备、诊断试剂和生物信息学工具等,通过不断的技术创新和市场拓展,为全球患者带来更好的医疗健康
收并购
Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides, biologics and biomarkers.
Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means less complications helping the rapid development of new drugs.
We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.
As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.
Visit our website at www.alderleyanalytical.com for more information.